Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 8 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 10 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
GO:0005783 | endoplasmic reticulum | 5 | 1 |
GO:0005794 | Golgi apparatus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: A4HBF2
Term | Name | Level | Count |
---|---|---|---|
GO:0006497 | protein lipidation | 5 | 1 |
GO:0006605 | protein targeting | 5 | 1 |
GO:0006612 | protein targeting to membrane | 5 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0006810 | transport | 3 | 1 |
GO:0006886 | intracellular protein transport | 4 | 1 |
GO:0008104 | protein localization | 4 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0015031 | protein transport | 4 | 1 |
GO:0018193 | peptidyl-amino acid modification | 5 | 1 |
GO:0018198 | peptidyl-cysteine modification | 6 | 1 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 7 | 1 |
GO:0018231 | peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine | 7 | 1 |
GO:0018345 | protein palmitoylation | 6 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0033036 | macromolecule localization | 2 | 1 |
GO:0036211 | protein modification process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0043543 | protein acylation | 5 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0045184 | establishment of protein localization | 3 | 1 |
GO:0046907 | intracellular transport | 3 | 1 |
GO:0051179 | localization | 1 | 1 |
GO:0051234 | establishment of localization | 2 | 1 |
GO:0051641 | cellular localization | 2 | 1 |
GO:0051649 | establishment of localization in cell | 3 | 1 |
GO:0051668 | localization within membrane | 3 | 1 |
GO:0070727 | cellular macromolecule localization | 3 | 1 |
GO:0071702 | organic substance transport | 4 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0071705 | nitrogen compound transport | 4 | 1 |
GO:0072657 | protein localization to membrane | 4 | 1 |
GO:0090150 | establishment of protein localization to membrane | 4 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 10 |
GO:0016409 | palmitoyltransferase activity | 5 | 10 |
GO:0016417 | S-acyltransferase activity | 5 | 10 |
GO:0016740 | transferase activity | 2 | 10 |
GO:0016746 | acyltransferase activity | 3 | 10 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 10 |
GO:0019706 | protein-cysteine S-palmitoyltransferase activity | 4 | 10 |
GO:0019707 | protein-cysteine S-acyltransferase activity | 3 | 10 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 10 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 163 | 165 | PF00675 | 0.457 |
CLV_NRD_NRD_1 | 17 | 19 | PF00675 | 0.436 |
CLV_NRD_NRD_1 | 226 | 228 | PF00675 | 0.385 |
CLV_PCSK_FUR_1 | 14 | 18 | PF00082 | 0.473 |
CLV_PCSK_KEX2_1 | 14 | 16 | PF00082 | 0.465 |
CLV_PCSK_KEX2_1 | 163 | 165 | PF00082 | 0.500 |
CLV_PCSK_KEX2_1 | 17 | 19 | PF00082 | 0.426 |
CLV_PCSK_KEX2_1 | 225 | 227 | PF00082 | 0.363 |
CLV_PCSK_SKI1_1 | 173 | 177 | PF00082 | 0.571 |
CLV_PCSK_SKI1_1 | 18 | 22 | PF00082 | 0.341 |
CLV_PCSK_SKI1_1 | 245 | 249 | PF00082 | 0.420 |
DEG_APCC_DBOX_1 | 225 | 233 | PF00400 | 0.619 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.651 |
DEG_SCF_FBW7_1 | 50 | 57 | PF00400 | 0.386 |
DOC_CDC14_PxL_1 | 36 | 44 | PF14671 | 0.447 |
DOC_CKS1_1 | 51 | 56 | PF01111 | 0.467 |
DOC_MAPK_FxFP_2 | 252 | 255 | PF00069 | 0.521 |
DOC_MAPK_gen_1 | 185 | 195 | PF00069 | 0.345 |
DOC_MAPK_gen_1 | 225 | 232 | PF00069 | 0.515 |
DOC_MAPK_gen_1 | 63 | 73 | PF00069 | 0.211 |
DOC_MAPK_HePTP_8 | 65 | 77 | PF00069 | 0.233 |
DOC_MAPK_MEF2A_6 | 188 | 197 | PF00069 | 0.392 |
DOC_MAPK_MEF2A_6 | 63 | 71 | PF00069 | 0.359 |
DOC_PP1_RVXF_1 | 186 | 193 | PF00149 | 0.254 |
DOC_PP4_FxxP_1 | 252 | 255 | PF00568 | 0.701 |
DOC_WW_Pin1_4 | 183 | 188 | PF00397 | 0.297 |
DOC_WW_Pin1_4 | 50 | 55 | PF00397 | 0.447 |
LIG_14-3-3_CanoR_1 | 185 | 191 | PF00244 | 0.291 |
LIG_14-3-3_CanoR_1 | 212 | 216 | PF00244 | 0.511 |
LIG_14-3-3_CanoR_1 | 245 | 255 | PF00244 | 0.678 |
LIG_Actin_WH2_2 | 197 | 214 | PF00022 | 0.447 |
LIG_Actin_WH2_2 | 229 | 247 | PF00022 | 0.625 |
LIG_APCC_ABBA_1 | 67 | 72 | PF00400 | 0.272 |
LIG_APCC_ABBAyCdc20_2 | 66 | 72 | PF00400 | 0.233 |
LIG_BRCT_BRCA1_1 | 236 | 240 | PF00533 | 0.629 |
LIG_BRCT_BRCA1_1 | 248 | 252 | PF00533 | 0.655 |
LIG_eIF4E_1 | 132 | 138 | PF01652 | 0.444 |
LIG_FHA_1 | 47 | 53 | PF00498 | 0.347 |
LIG_FHA_1 | 62 | 68 | PF00498 | 0.306 |
LIG_LIR_Apic_2 | 249 | 255 | PF02991 | 0.697 |
LIG_LIR_Gen_1 | 189 | 200 | PF02991 | 0.262 |
LIG_LIR_Gen_1 | 207 | 216 | PF02991 | 0.410 |
LIG_LIR_Nem_3 | 189 | 195 | PF02991 | 0.294 |
LIG_LIR_Nem_3 | 207 | 211 | PF02991 | 0.410 |
LIG_LIR_Nem_3 | 214 | 218 | PF02991 | 0.541 |
LIG_NRBOX | 81 | 87 | PF00104 | 0.446 |
LIG_Pex14_2 | 248 | 252 | PF04695 | 0.610 |
LIG_PTB_Apo_2 | 148 | 155 | PF02174 | 0.444 |
LIG_SH2_CRK | 156 | 160 | PF00017 | 0.308 |
LIG_SH2_CRK | 213 | 217 | PF00017 | 0.591 |
LIG_SH2_NCK_1 | 258 | 262 | PF00017 | 0.531 |
LIG_SH2_STAP1 | 213 | 217 | PF00017 | 0.591 |
LIG_SH2_STAT5 | 132 | 135 | PF00017 | 0.444 |
LIG_SH2_STAT5 | 213 | 216 | PF00017 | 0.535 |
LIG_SH3_3 | 227 | 233 | PF00018 | 0.660 |
LIG_SH3_3 | 48 | 54 | PF00018 | 0.447 |
LIG_SH3_3 | 85 | 91 | PF00018 | 0.471 |
LIG_SUMO_SIM_par_1 | 196 | 201 | PF11976 | 0.468 |
LIG_SUMO_SIM_par_1 | 48 | 53 | PF11976 | 0.322 |
LIG_SUMO_SIM_par_1 | 84 | 90 | PF11976 | 0.444 |
LIG_TRAF2_1 | 58 | 61 | PF00917 | 0.276 |
LIG_TYR_ITIM | 211 | 216 | PF00017 | 0.444 |
LIG_WRC_WIRS_1 | 205 | 210 | PF05994 | 0.485 |
MOD_CDK_SPK_2 | 183 | 188 | PF00069 | 0.211 |
MOD_CK1_1 | 169 | 175 | PF00069 | 0.354 |
MOD_CK1_1 | 186 | 192 | PF00069 | 0.361 |
MOD_CK1_1 | 56 | 62 | PF00069 | 0.362 |
MOD_CK2_1 | 232 | 238 | PF00069 | 0.495 |
MOD_GlcNHglycan | 118 | 121 | PF01048 | 0.322 |
MOD_GlcNHglycan | 4 | 7 | PF01048 | 0.366 |
MOD_GlcNHglycan | 77 | 80 | PF01048 | 0.467 |
MOD_GSK3_1 | 179 | 186 | PF00069 | 0.320 |
MOD_GSK3_1 | 2 | 9 | PF00069 | 0.724 |
MOD_GSK3_1 | 200 | 207 | PF00069 | 0.437 |
MOD_GSK3_1 | 246 | 253 | PF00069 | 0.567 |
MOD_GSK3_1 | 46 | 53 | PF00069 | 0.342 |
MOD_N-GLC_1 | 250 | 255 | PF02516 | 0.466 |
MOD_N-GLC_2 | 129 | 131 | PF02516 | 0.361 |
MOD_NEK2_1 | 193 | 198 | PF00069 | 0.319 |
MOD_NEK2_1 | 211 | 216 | PF00069 | 0.463 |
MOD_NEK2_1 | 240 | 245 | PF00069 | 0.577 |
MOD_NEK2_2 | 220 | 225 | PF00069 | 0.619 |
MOD_PIKK_1 | 56 | 62 | PF00454 | 0.268 |
MOD_PK_1 | 16 | 22 | PF00069 | 0.518 |
MOD_PKA_1 | 16 | 22 | PF00069 | 0.518 |
MOD_PKA_1 | 163 | 169 | PF00069 | 0.211 |
MOD_PKA_2 | 16 | 22 | PF00069 | 0.671 |
MOD_PKA_2 | 163 | 169 | PF00069 | 0.357 |
MOD_PKA_2 | 211 | 217 | PF00069 | 0.481 |
MOD_PKB_1 | 14 | 22 | PF00069 | 0.527 |
MOD_Plk_1 | 250 | 256 | PF00069 | 0.529 |
MOD_Plk_4 | 193 | 199 | PF00069 | 0.238 |
MOD_Plk_4 | 200 | 206 | PF00069 | 0.242 |
MOD_Plk_4 | 211 | 217 | PF00069 | 0.376 |
MOD_Plk_4 | 46 | 52 | PF00069 | 0.291 |
MOD_ProDKin_1 | 183 | 189 | PF00069 | 0.297 |
MOD_ProDKin_1 | 50 | 56 | PF00069 | 0.444 |
MOD_SUMO_rev_2 | 56 | 65 | PF00179 | 0.265 |
TRG_DiLeu_BaEn_2 | 79 | 85 | PF01217 | 0.339 |
TRG_ENDOCYTIC_2 | 132 | 135 | PF00928 | 0.405 |
TRG_ENDOCYTIC_2 | 156 | 159 | PF00928 | 0.300 |
TRG_ENDOCYTIC_2 | 213 | 216 | PF00928 | 0.531 |
TRG_ENDOCYTIC_2 | 218 | 221 | PF00928 | 0.599 |
TRG_ER_diArg_1 | 14 | 17 | PF00400 | 0.680 |
TRG_ER_diArg_1 | 162 | 164 | PF00400 | 0.297 |
TRG_ER_diArg_1 | 224 | 227 | PF00400 | 0.572 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I0L0 | Leptomonas seymouri | 49% | 100% |
A0A1X0PBJ7 | Trypanosomatidae | 28% | 100% |
A0A3R7M6T4 | Trypanosoma rangeli | 27% | 100% |
A0A3S7X8K2 | Leishmania donovani | 71% | 100% |
A4IAK1 | Leishmania infantum | 74% | 100% |
E9B5M5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 69% | 100% |
Q4Q2B1 | Leishmania major | 70% | 100% |
V5BW09 | Trypanosoma cruzi | 28% | 100% |